Thind Munveer, Oraii Alireza, Chaumont Corentin, Arceluz Martín R, Sekigawa Masahiro, Yogasundaram Haran, Sugrue Alan, Mirwais Maiwand, AlSalem Ahmed B, Zado Erica S, Guandalini Gustavo S, Markman Timothy M, Deo Rajat, Schaller Robert D, Dixit Sanjay, Epstein Andrew E, Supple Gregory E, Tschabrunn Cory M, Santangeli Pasquale, Callans David J, Hyman Matthew C, Nazarian Saman, Frankel David S, Marchlinski Francis E
Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Heart Rhythm. 2024 Jun;21(6):806-811. doi: 10.1016/j.hrthm.2024.01.048. Epub 2024 Jan 29.
Targeting non-pulmonary vein triggers (NPVTs) after pulmonary vein isolation may reduce atrial fibrillation (AF) recurrence. Isoproterenol infusion and cardioversion of spontaneous or induced AF can provoke NPVTs but typically require vasopressor support and increased procedural time.
The purpose of this study was to identify risk factors for the presence of NPVTs and create a risk score to identify higher-risk subgroups.
Using the AF ablation registry at the Hospital of the University of Pennsylvania, we included consecutive patients who underwent AF ablation between January 2021 and December 2022. We excluded patients who did not receive NPVT provocation testing after failing to demonstrate spontaneous NPVTs. NPVTs were defined as non-pulmonary vein ectopic beats triggering AF or focal atrial tachycardia. We used risk factors associated with NPVTs with P <.1 in multivariable logistic regression model to create a risk score in a randomly split derivation set (80%) and tested its predictive accuracy in the validation set (20%).
In 1530 AF ablations included, NPVTs were observed in 235 (15.4%). In the derivation set, female sex (odds ratio [OR] 1.40; 95% confidence interval [CI] 0.96-2.03; P = .080), sinus node dysfunction (OR 1.67; 95% CI 0.98-2.87; P = .060), previous AF ablation (OR 2.50; 95% CI 1.70-3.65; P <.001), and left atrial scar (OR 2.90; 95% CI 1.94-4.36; P <.001) were risk factors associated with NPVTs. The risk score created from these risk factors (PRESSS score; [PRE]vious ablation: 2 points, female [S]ex: 1 point, [S]inus node dysfunction: 1 point, left atrial [S]car: 2 points) had good predictive accuracy in the validation cohort (area under the receiver operating characteristic curve 0.728; 95% CI 0.648-0.807).
A risk score incorporating predictors for NPVTs may allow provocation of triggers to be performed in patients with greatest expected yield.
肺静脉隔离后靶向非肺静脉触发灶(NPVTs)可能会降低房颤(AF)复发率。静脉输注异丙肾上腺素以及对自发或诱发的房颤进行复律可诱发NPVTs,但通常需要血管升压药支持且会增加手术时间。
本研究旨在确定NPVTs存在的危险因素,并创建一个风险评分以识别高风险亚组。
利用宾夕法尼亚大学医院的房颤消融登记系统,我们纳入了2021年1月至2022年12月期间连续接受房颤消融的患者。我们排除了在未显示出自发性NPVTs后未接受NPVT激发试验的患者。NPVTs被定义为触发房颤或局灶性房性心动过速的非肺静脉异位搏动。我们在多变量逻辑回归模型中使用与NPVTs相关且P<0.1的危险因素,在随机划分的推导集(80%)中创建一个风险评分,并在验证集(20%)中测试其预测准确性。
在纳入的1530例房颤消融病例中,235例(15.4%)观察到NPVTs。在推导集中,女性(比值比[OR]1.40;95%置信区间[CI]0.96 - 2.03;P = 0.080)、窦房结功能障碍(OR 1.67;95%CI 0.98 - 2.87;P = 0.060)、既往房颤消融史(OR 2.50;95%CI 1.70 - 3.65;P <0.001)和左心房瘢痕(OR 2.90;95%CI 1.94 - 4.36;P <0.001)是与NPVTs相关的危险因素。由这些危险因素创建的风险评分(PRESSS评分;[PRE]vious消融:2分,女性[ S]ex:1分,[S]inus结功能障碍:1分,左心房[ S]car:2分)在验证队列中具有良好的预测准确性(受试者工作特征曲线下面积为0.728;95%CI 0.648 - 0.807)。
纳入NPVTs预测指标的风险评分可能有助于在预期获益最大的患者中进行触发灶激发。